New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - oxybutynin hydrochloride 1 mg/ml;   - syrup - 1 mg/ml - active: oxybutynin hydrochloride 1 mg/ml   excipient: berry flavour (mix) 538632 citric acid monohydrate fast green fcf glycerol methyl hydroxybenzoate purified water sodium citrate dihydrate sorbitol as 70% solution, 366 mg/ml sucrose - oxybutynin chloride is indicated in adults and children over 5 years of age for the management of urgency and incontinence that characterise neurogenic bladder disorders and idiopathic destrusor instability.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

farco-pharma gmbh - oxybutynin hydrochloride 1,004 mg/ml - eq. oxybutynin hydrochloride 1000 mg/g - intravesical solution - 1 mg/ml - oxybutynin hydrochloride 1.004 mg/ml - oxybutynin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

medice arzneimittel pütter gmbh & co. kg - oxybutynin hydrochloride 1,004 mg/ml - intravesical solution - 1 mg/ml - oxybutynin hydrochloride 1.004 mg/ml - oxybutynin

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - oxybutynin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - oxybutynin hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - oxybutynin hydrochloride - tablets - 2.5 milligram - oxybutynin

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - oxybutynin hydrochloride - tablets - 5 milligram - oxybutynin

Ireland - English - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - oxybutynin hydrochloride - oral solution - 2.5 mg/5ml - oxybutynin - anticholinergic as well as antispasmodic - urinary incontinence, urgency and frequency in the unstable bladder, whether due to neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as multiple sclerosis and spina bifida, or to idiopathic detrusor instability (motor urge incontinence).

Ireland - English - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - oxybutynin hydrochloride - oral solution - 5 mg/5ml - oxybutynin - anticholinergic as well as antispasmodic - urinary incontinence, urgency and frequency in the unstable bladder, whether due to neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as multiple sclerosis and spina bifida, or to idiopathic detrusor instability (motor urge incontinence).

Ireland - English - HPRA (Health Products Regulatory Authority)

genthon b.v. - oxybutynin hydrochloride - tablet - 5 milligram(s) - drugs for urinary frequency and incontinence; oxybutynin